{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T02:46:00Z","timestamp":1769741160308,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00417-021-05533-1","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:05:01Z","timestamp":1642982701000},"page":"1707-1712","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Medical cannabis oil for benign essential blepharospasm: a prospective, randomized controlled pilot study"],"prefix":"10.1007","volume":"260","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3548-424X","authenticated-orcid":false,"given":"Ofira","family":"Zloto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alon","family":"Weisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inbal","family":"Avisar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tal","family":"Serlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihi","family":"Bar-lev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayelet","family":"Priel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daphna","family":"Landau Prat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nira","family":"Granot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Weisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Ben Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"issue":"Pt 4","key":"5533_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/eye.1988.79","volume":"2","author":"JS Elston","year":"1988","unstructured":"Elston JS, Marsden CD, Grandas F, Quinn NP (1988) The significance of ophthalmological symptoms in idiopathic blepharospasm. Eye (Lond) 2(Pt 4):435\u2013439","journal-title":"Eye (Lond)"},{"key":"5533_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1001\/archopht.1985.01050030043017","volume":"103","author":"AB Scott","year":"1985","unstructured":"Scott AB, Kennedy RA, Stubbs HA (1985) Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol (Chicago, Ill 1960) 103:347\u201350","journal-title":"Arch Ophthalmol (Chicago, Ill 1960)"},{"key":"5533_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1017\/S0317167100027748","volume":"15","author":"SP Kraft","year":"1988","unstructured":"Kraft SP, Lang AE (1988) Botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, and eyelid fasciculations. Can J Neurol Sci 15:276\u2013280","journal-title":"Can J Neurol Sci"},{"key":"5533_CR4","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1136\/bjo.80.12.1073","volume":"80","author":"JA Mauriello","year":"1996","unstructured":"Mauriello JA, Dhillon S, Leone T et al (1996) Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11 years. Br J Ophthalmol 80:1073\u20131076","journal-title":"Br J Ophthalmol"},{"key":"5533_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/01.iio.0000167238.26526.a8","volume":"45","author":"GJ Ben Simon","year":"2005","unstructured":"Ben Simon GJ, McCann JD (2005) Benign essential blepharospasm. Int Ophthalmol Clin 45:49\u201375","journal-title":"Int Ophthalmol Clin"},{"key":"5533_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1055\/s-0036-1571952","volume":"36","author":"BI Karp","year":"2016","unstructured":"Karp BI, Alter K (2016) Botulinum toxin treatment of blepharospasm, orofacial\/oromandibular dystonia, and hemifacial spasm. Semin Neurol 36:84\u201391","journal-title":"Semin Neurol"},{"key":"5533_CR7","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/mds.21495","volume":"22","author":"M Obermann","year":"2007","unstructured":"Obermann M, Yaldizli O, De Greiff A et al (2007) Morphometric changes of sensorimotor structures in focal dystonia. Mov Disord 22:1117\u20131123","journal-title":"Mov Disord"},{"key":"5533_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/IIO.0000000000000210","volume":"58","author":"MT Yen","year":"2018","unstructured":"Yen MT (2018) Blepharospasm and hemifacial spasm. Int Ophthalmol Clin 58:1","journal-title":"Int Ophthalmol Clin"},{"key":"5533_CR9","doi-asserted-by":"publisher","unstructured":"Green KE, Rastall D, Eggenberger E (2017) Treatment of blepharospasm\/hemifacial spasm. Curr Treat Options Neurol 19(11):41. https:\/\/doi.org\/10.1007\/s11940-017-0475-0","DOI":"10.1007\/s11940-017-0475-0"},{"key":"5533_CR10","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/jnc.14098","volume":"142","author":"BS Basavarajappa","year":"2017","unstructured":"Basavarajappa BS, Shivakumar M, Joshi V, Subbanna S (2017) Endocannabinoid system in neurodegenerative disorders. J Neurochem 142:624\u2013648","journal-title":"J Neurochem"},{"key":"5533_CR11","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1586\/14737175.2014.985209","volume":"14","author":"SR Benbadis","year":"2014","unstructured":"Benbadis SR, Sanchez-Ramos J, Bozorg A et al (2014) Medical marijuana in neurology. Expert Rev Neurother 14:1453\u20131465","journal-title":"Expert Rev Neurother"},{"key":"5533_CR12","doi-asserted-by":"crossref","unstructured":"Joshi N, Onaivi ES (2019) Endocannabinoid system components: overview and tissue distribution. In: Advances in Experimental Medicine and Biology. Adv Exp Med Biol, pp 1\u201312","DOI":"10.1007\/978-3-030-21737-2_1"},{"key":"5533_CR13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1212\/01.wnl.0000267407.79757.75","volume":"69","author":"E Benarroch","year":"2007","unstructured":"Benarroch E (2007) Endocannabinoids in basal ganglia circuits: implications for Parkinson disease. Neurology 69:306\u2013309","journal-title":"Neurology"},{"key":"5533_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0885-3924(02)00426-8","volume":"24","author":"A Chatterjee","year":"2002","unstructured":"Chatterjee A, Almahrezi W, Fitzcharles, (2002) A dramatic response to inhaled cannabis in a woman with central thalamic pain and dystonia [3]. J Pain Symptom Manage 24:4\u20136","journal-title":"J Pain Symptom Manage"},{"key":"5533_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/mds.20268","volume":"20","author":"MC Uribe Roca","year":"2005","unstructured":"Uribe Roca MC, Micheli F, Viotti R (2005) Cannabis sativa and dystonia secondary to Wilson\u2019s disease. Mov Disord 20:113\u2013115","journal-title":"Mov Disord"},{"key":"5533_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/mds.26142","volume":"30","author":"B Kluger","year":"2015","unstructured":"Kluger B, Triolo P, Jones W, Jankovic J (2015) The therapeutic potential of cannabinoids for movement disorders. Mov Disord 30:313\u2013327","journal-title":"Mov Disord"},{"key":"5533_CR17","first-page":"45","volume":"25","author":"B Gauter","year":"2004","unstructured":"Gauter B, Rukwied R, Konrad C (2004) Cannabinoid agonists in the treatment of blepharospasm-a case report study. Neuroendocrinol Lett 25:45\u201348","journal-title":"Neuroendocrinol Lett"},{"key":"5533_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/bs.pmbts.2015.10.002","volume":"137","author":"PJ Ronan","year":"2016","unstructured":"Ronan PJ, Wongngamnit N, Beresford TP (2016) Molecular mechanisms of cannabis Signaling in the brain. Prog Mol Biol Transl Sci 137:123\u2013147","journal-title":"Prog Mol Biol Transl Sci"},{"key":"5533_CR19","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/epi.12631","volume":"55","author":"O Devinsky","year":"2014","unstructured":"Devinsky O, Cilio MR, Cross H et al (2014) Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia 55:791\u2013802","journal-title":"Epilepsia"},{"key":"5533_CR20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/01658107.2017.1318150","volume":"41","author":"PM Radke","year":"2017","unstructured":"Radke PM, Mokhtarzadeh A, Lee MS, Harrison AR (2017) Medical cannabis, a beneficial high in treatment of blepharospasm? An early observation. Neuro-Ophthalmology 41:253\u2013258","journal-title":"Neuro-Ophthalmology"},{"key":"5533_CR21","doi-asserted-by":"publisher","first-page":"205031212110009","DOI":"10.1177\/20503121211000909","volume":"9","author":"A Kichloo","year":"2021","unstructured":"Kichloo A, Albosta M, Aljadah M et al (2021) Marijuana: a systems-based primer of adverse effects associated with use and an overview of its therapeutic utility. SAGE Open Med 9:20503121211000908","journal-title":"SAGE open Med"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05533-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-021-05533-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05533-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T10:12:23Z","timestamp":1649931143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-021-05533-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["5533"],"URL":"https:\/\/doi.org\/10.1007\/s00417-021-05533-1","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]},"assertion":[{"value":"3 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients signed an informed consent prior to study entry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The study was approved by the local institutional review board (IRB) of the Sheba Medical Center.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}